Ardian nabs $30M to treat heart failure

Ardian, maker of a device used to treat symptoms of congestive heart failure, just brought in $30 million of an anticipated $60 million third round of capital, according to peHUB. Backers of the Menlo Park, Calif. company include Advanced Technology Ventures, Morgenthaler Ventures and St. Paul Venture Capital. It previously raised $18 million.

Founded in 2003, the tiny, web site-less firm was initially incubated at the Foundry.

Next Story:
Previous Story:

About the Author,

Camille was the lead writer for GreenBeat until August 2010. To reach VentureBeat's current writers, email tips@venturebeat.com.

blog comments powered by Disqus